Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography

Journal of the Neurological Sciences

Volumn 148, Issue 2, 1997, Pages 131-137

  Araki, Tsutomu ^a   Kato, Hiroyuki ^a   Shuto, Katsuro ^b   Fujiwara, Takehiko ^c   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Pharmacological Research Laboratory   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Aging; Dopamine D1 receptor; Dopamine D2 receptor; Dopamine uptake sites; Rat; Receptor autoradiography

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; EMONAPRIDE; MAZINDOL; SPIPERONE;

AGING; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AGING; ANIMALS; AUTORADIOGRAPHY; BENZAMIDES; BRAIN CHEMISTRY; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; MAZINDOL; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SPIPERONE; TRITIUM;

EID: 0031589981     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)05343-9     Document Type: Article

References (57)

1. 3H]GBR-12935 in human putamen. Neurobiol. Aging, 10: 661-664.
2. Altar, C.A., O'Neil, S., Walter, R.J., Jr. and Marshall, J.F. (1985) Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography. Science, 228: 597-600.
3. Araki, T., Kato, H., Kogure, K. and Kanai, Y. (1992a) Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischaemia. Br. J. Pharmacol., 107: 437-442.
4. 3H]inositol 1,4,5-trisphosphate in the gerbil brain: An autoradiographic study. Neuroscience, 46: 973-980.
5. Araki, T., Kato, H., Kogure, K., Shuto, K. and Ishida, Y. (1992c) Autoradiographic mapping of neurotransmitter system receptors in mammalian brain. Pharmacol. Biochem. Behav., 41: 539-542.
6. Araki, T., Murakami, F., Kanai, Y., Kato, K. and Kogure, K. (1993) Changes of spirodecanone binding in the gerbil hippocampus after cerebral ischemia. Neuroreport, 5: 37-40.
7. Ben-Shachar, D., Zuk, R. and Glinka, Y. (1995) Dopamine neurotoxicity: Inhibition of mitochondria respiration. J. Neurochem., 64(7): 18-723.
8. 2, and spirodecanone binding sites in rat forebrain. J. Neurochem., 40: 1227-1236.
9. Carlsson, A. and Winblad, B. (1976) Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J. Neural. Transm., 38: 271-301.
10. 3H]mazindol. Neuroscience, 49: 317-327.
11. Choen, G. and Spina, M.B. (1989) Deprenyl suppress the oxidant stress associated with increased dopamine turnover. Ann. Neurol., 26: 689-690.
12. 3H]SCH 23390. Eur. J. Pharmacol., 108: 323-325.
13. Dawson, T.M., Gehlert, D.R., McCabe, R.T., Barnett, A. and Wamsley, J.K. (1986) D-1 dopamine receptors in the rat brain: A quantitative autoradiographic analysis. J. Neurosci., 6: 2352-2365.
14. De Blasi, A. and Mennini, T. (1982) Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats. Brain Res., 242: 361-364.
15. DeKeyser, J., Ebinger, G. and Vauquelin, G. (1990) Age-related changes in the human nigrostriatal dopaminergic system. Ann. Neurol., 27: 157-161.
16. Filloux, F. and Townsend, J.J. (1993) Pre- and postsynaptic neurotoxic effect of dopamine demonstrated by intrastriatal injection. Exp. Neurol., 119: 79-88.
17. Finch, C.E., Marshall, J.F. and Randall, P.K. (1981) Aging and basal ganglia functions. Annu. Rev. Gerontol. Geriatr., 2: 49-87.
18. Fornstedt, B. (1990) Role of catechol autooxidation in the degeneration of dopamine neurons. Acta Neurol. Scand. (Suppl.)., 129: 12-14.
19. Garau, L., Govoni, S., Stefanni, E. and Trabucchi, T. (1978) Dopamine receptors: Pharmacological and anatomical evidence indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci., 23: 1745-1750.
20. Giorgi, O., De Montis, G., Porceddu, M.L., Mele, S., Calderini, G., Toffano, G. and Biggio, G. (1987) Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum. Dev. Brain Res., 35: 283-290.
21. Graham, D.G. (1978) Oxidative pathway for catecholamines in the genesis of neuromelanine and cytotoxic quinones. Mol. Pharmacol., 14: 633-643.
22. Graham, D.G. (1984) Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology, 5: 83-96.
23. Halliwell, B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem., 59: 1609-1623.
24. Henry, J.M., Filburn, C.R., Joseph, J.A. and Roth, G.S. (1986) Effect of aging on striatal dopamine receptor subtypes in Wistar rats. Neurobiol. Aging, 7: 357-361.
25. Hara, H., Onodera, H., Kato, H. and Kogure, K. (1992) Effects of aging on signal transmission and transduction systems in the gerbil brain: Morphological and autoradiographic study. Neuroscience, 46: 475-488.
26. Hess, E.J., Bracha, S., Kleinman, J.E. and Creese, I. (1987) Dopamine receptor subtype imbalance in schizophrenia. Life Sci., 40: 1487-1497.
27. 3H-spiperone binding sites in various areas of the rat limbic system. Mol. Pharmacol., 15: 506-514.
28. Hyttel, J. (1987) Age-related decrease in the density of dopamine D1 and D2 receptors in corpus striatum of rats. Pharmacol. Toxic., 61: 126-129.
29. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol., 36: 35-44.
30. 3H]mazindol autoradiography. J. Neurosci., 5: 1513-1521.
31. Joyce, J.N. (1993) Differential response of striatal dopamine receptor subtypes and cholinergic muscarinic receptors to the loss of dopamine, III, Effects in Parkinson's disease. Brain Res., 600: 156-160.
32. Joseph, J. and Roth, G., Age-related alterations in dopamine mechanisms. In: Samuel, D., Algeri, S., Gershon, S., Grimm, V.E. and Toffaro, G. (eds.), Aging of the Brain, Ravan, New York, NY, 1983, pp. 245-256.
33. Kebabian, J.W. and Calne, D.B. (1979) Multiple receptors for dopamine. Nature, 277: 93-96.
34. 3H-spiperone in rat brain. Brain Res., 169: 1-9.
35. Leysen, J.E., Niemegeers, C.J.E., Tollenaere, J.P. and Laduron, P.M. (1978) Serotonergic component of neuroleptic receptors. Nature, 272: 168-171.
36. Lohr, J.B. and Bracha, H.S. (1988) Association of psychosis and movement disorders in the elderly. Psychiatr. Clin. North. Am., 11: 61-81.
37. Marshall, J.F. and Berrios, N. (1979) Movement disorders in aged rats: Reversal by dopamine receptor stimulation. Science, 206: 477-479.
38. Marshall, J.F. (1982) Sensorimotor disturbances in the aging rodent. J. Gerontol., 37: 548-554.
39. Marshall, J.S. and Joyce, J.N. (1988) Basal ganglia dopamine receptor autoradiography and age-related movement disorders. Ann. NY Acad. Sci. USA., 515: 215-225.
40. 2 receptors. Neuroscience, 36: 403-410.
41. Morgan, D.E. (1987) The dopamine and serotonin systems during in human and rodent brains: A brief review. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 11: 153-157.
42. Morgan, D.G. and Finch, C.E. (1988) Dopaminergic changes in the basal ganglia. A generalized phenomenon of aging in mammals. Ann. NY Acad. Sci. USA., 515: 145-160.
43. Murray, A.M., Weihmueller, F.B., Marshall, J.F., Hurtig, H.I., Gottleib, G.L. and Joyce, J.N. (1995) Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with Parkinsonism. Ann. Neurol., 37: 300-312.
44. Mytilineou, C., Han, S.-K. and Cohen, G. (1993) Toxic and protective effects of L-DOPA on mesenceohalic cell cultures. J Neurochem., 61: 1470-1478.
45. 2 receptors mediating inhibition of adenylate cyclase in rats. Eur. J. Pharmacol., 99: 127-128.
46. 3H]Spiperone binding sites in brain: Autoradiographic localization of multiple receptor. Brain Res., 213: 277-289.
47. 2 receptors and uptake sites: A quantitative autoradiographic study. J. Neurochem., 57: 1951-1961.
48. Richfield, E.K., Young, A.B. and Penney, J.B. (1987) Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtle, pigeon, rat, cat and monkey. J. Comp. Neurol., 262: 446-463.
49. Rinne, J.O., Lonnberg, P. and Marjamaki, P. (1990) Age-dependent decline in human brain dopamine D-1 and D-2 receptors. Brain Res., 508: 349-352.
50. 11C]raclopride. J. Cereb. Blood Flow Metab., 13: 310-314.
51. Seeman, P., Bzowej, N.H., Guan, H.-G., Bergeron, C., Becker, L.E., Reynolds, G.P., Bird, E.D., Piederer, P., Jellinger, K., Watanabe, S. and Tourtellotte, W.W. (1987) Human brain dopamine receptors in children and aging adults. Synapse, 1: 399-404.
52. 3H]dopamine uptake in rat striatum during aging. J. Neurochem., 56: 575-579.
53. 2 dopamine receptors in effluxes of cyclic AMP from rat neostriatum. Nature, 294: 366-368.
54. Tanaka, M., Sotomatsu, A., Kanai, H. and Hirai, S. (1991) Dopa and dopamine cause cultured neuronal death in the presence of iron. J. Neurol. Sci., 101: 198-203.
55. Ulas, J., Weihmuller, F.B., Brunner, L.C., Joyce, J.N., Marshall, J.F. and Cotman, C.W. (1994) Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: An autoradiographic study. J Neurosci., 14: 6317-6324.
56. 3H]-YM 01951-2: A ligand for labelling dopamine D-2 receptors. Life Sci., 47: PL-151-PL-155.
57. Zelnik, N., Angel, I., Paul, S.M. and Kleinman, J.E. (1986) Decreased density of human stroatal dopamine uptake sites with age. Eur. J. Pharmacol., 126: 175-176.